MiR-135A1 is highly produced in colon cancer specimens along with cell lines, while the level of the clinical significance of cyclin G2 (CCNG2), which can inhibit cell proliferation and promote apoptosis, is negatively correlated with miR-135A1 in human CRC tissues. Here, CCNG2 is linked to colonic neoplasm.